Rice Hall James & Associates LLC Has $2.55 Million Stock Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

Rice Hall James & Associates LLC raised its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 19.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 91,500 shares of the technology company’s stock after buying an additional 14,871 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Simulations Plus were worth $2,552,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in SLP. nVerses Capital LLC increased its stake in shares of Simulations Plus by 1,100.0% in the 3rd quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock valued at $38,000 after purchasing an additional 1,100 shares during the last quarter. Tributary Capital Management LLC increased its stake in shares of Simulations Plus by 54.7% in the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock valued at $10,425,000 after purchasing an additional 115,122 shares during the last quarter. Semanteon Capital Management LP bought a new position in shares of Simulations Plus in the 3rd quarter valued at $358,000. Congress Asset Management Co. increased its stake in shares of Simulations Plus by 22.5% in the 3rd quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock valued at $6,613,000 after purchasing an additional 37,914 shares during the last quarter. Finally, US Bancorp DE increased its stake in shares of Simulations Plus by 37.0% in the 3rd quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock valued at $159,000 after purchasing an additional 1,343 shares during the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. Stephens began coverage on Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 price target on the stock. BTIG Research reduced their price objective on Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. KeyCorp boosted their price objective on Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, StockNews.com lowered Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Simulations Plus has a consensus rating of “Moderate Buy” and a consensus target price of $49.40.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $31.76, for a total transaction of $635,200.00. Following the transaction, the director now directly owns 3,442,584 shares of the company’s stock, valued at approximately $109,336,467.84. The trade was a 0.58 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 19.40% of the company’s stock.

Simulations Plus Trading Down 1.2 %

Shares of SLP opened at $35.99 on Wednesday. The company has a market capitalization of $723.04 million, a PE ratio of 89.98 and a beta of 0.83. Simulations Plus, Inc. has a 12 month low of $24.00 and a 12 month high of $51.22. The stock’s 50-day moving average price is $31.50 and its two-hundred day moving average price is $32.19.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.